Stock GENNEX6 GENNEX LABORATORIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Gennex Laboratories Limited

Equities

GENNEX6

INE509C01026

Market Closed - Bombay S.E.
Other stock markets
 11:25:44 31/05/2024 BST 		5-day change 1st Jan Change
17.16 INR +1.00% Intraday chart for Gennex Laboratories Limited -9.06% +2.08%
02-14 Gennex Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
02-14 Gennex Laboratories Limited Appoints Dr. S. Ch. Dharma Rao as Additional Director (Non- Executive - Non Independent Director) CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Gennex Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Gennex Laboratories Limited Appoints Dr. S. Ch. Dharma Rao as Additional Director (Non- Executive - Non Independent Director)
CI
Gennex Laboratories Limited Announces Resignation of Tiruvarur Muralidharan Gopalakrishnan as Whole Time Director
CI
Gennex Laboratories Gets Good Manufacturing Practices Certificate from Indian Regulator
MT
Gennex Laboratories Limited announced that it expects to receive INR 966.125 million in funding from Premier Fiscal Services Pvt Ltd
CI
Gennex Laboratories Board to Consider Raising Funds Via Equity
MT
Gennex Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
CI
Gennex Laboratories Gets Permission to Manufacture, Sell Fexofenadine, Minoxidil
MT
Gennex Laboratories Limited Obtains Approval of Additional Products from Drug Control Administration, Government of Telangana
CI
Gennex Laboratories Gets WHO-GMP Certification from Drug Control Administration, Government of Telangana
MT
Gennex Laboratories Arm Gets Drug Manufacturing License
MT
Gennex Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2023
CI
Gennex Laboratories Limited Appoints Dinesh Kumar Kejriwal as Company Secretary & Compliance Officer
CI
Gennex Laboratories Limited completed the acquisition of 6.73% minority stake in Deccan Remedies Limited.
CI
Gennex Laboratories Limited Approves the Acceptance of Resignation of Rajesh Vankadara as Company Secretary & Compliance Officer
CI
Gennex Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
CI
Gennex Laboratories Limited Announces Rajesh Vankadara to Resign as Company Secretary & Compliance Officer Effect from February 26, 2023
CI
Gennex Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
CI
Gennex Laboratories : Letter of offer of Gennex Laboratories Limited (Final Offer Document filed with Stock Exchanges)
PU
Gennex Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GENNEX6 Stock
  4. News Gennex Laboratories Limited